All of the following statements about Clostridium difficile toxins are correct EXCEPT:

Explanation

## Clostridium difficile Toxins: Mechanism and Role ### Toxin A (Enterotoxin) **Key Point:** Toxin A is the primary pathogenic factor causing fluid secretion, mucosal inflammation, and damage to intestinal epithelium. - Acts as an enterotoxin - Causes increased vascular permeability - Triggers inflammatory response via IL-8 release ### Toxin B (Cytotoxin) **Key Point:** Toxin B is more potent in vitro and causes characteristic cytopathic effects. - Induces cell rounding and detachment - Causes cytoskeletal disruption - More potent than toxin A in cell culture assays ### Mechanism of Action **High-Yield:** Both toxins inactivate Rho GTPases (Rho, Rac, Cdc42) by catalyzing ADP-ribosylation of the glutamine residue at position 63. - This prevents GTP binding - Leads to loss of actin stress fiber organization - Results in cell rounding and apoptosis ### Clinical Significance **Clinical Pearl:** Both toxins A and B work synergistically in pathogenesis. Neither toxin alone is fully sufficient for severe disease — epidemiological and experimental evidence shows that strains producing both toxins cause more severe disease than single-toxin producers. Some hypervirulent strains (e.g., NAP1/BI/027) produce increased amounts of both toxins and binary toxin, leading to more severe infections. **Warning:** The statement that "toxin A alone is sufficient" is incorrect. While toxin A was historically thought to be the primary pathogen, modern understanding demonstrates that toxin B plays an equally or more important role, and synergy between the two is crucial for full pathogenic expression. | Feature | Toxin A | Toxin B | | --- | --- | --- | | Type | Enterotoxin | Cytotoxin | | Primary effect | Fluid secretion, inflammation | Cell rounding, cytoskeletal damage | | In vitro potency | Lower | Higher | | In vivo role | Mucosal damage, fluid loss | Epithelial barrier disruption | | Target | Rho GTPases | Rho GTPases | | Mechanism | ADP-ribosylation | ADP-ribosylation |